The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

94 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORSBDB
Chiesi Farmaceutici
BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORSBDB
Janssen Biotech
SMALL-MOLECULE MODULATORS OF THE ORPHAN NUCLEAR RECEPTOR TLXBDB
Baylor College Of Medicine
MODIFIED IMIDAZOPYRIDINES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORSBDB
Merck Sharp & Dohme
Glutarimides for medical treatmentBDB
C4 Therapeutics
Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amineBDB
Kronos Bio
DACOS type NNRTIS amino acid ester derivative, preparation method thereof, pharmaceutical composition, and application thereofBDB
Yunnan University
Benzimidazole and indole compounds and uses thereofBDB
Incyte
Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonistsBDB
Bristol-Myers Squibb
Pyridazinone compounds and their use as DAAO inhibitorsBDB
Takeda Pharmaceutical
Substituted isoquionline derivatives as immunomudulatorsBDB
Bristol-Myers Squibb
Pyrimidine FGFR4 inhibitorsBDB
Eisai R&D Management
Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapyBDB
Auckland Uniservices
Amino acid compounds and methods of useBDB
Pliant Therapeutics
Spirocycle compounds and methods of making and using sameBDB
Lundbeck La Jolla Research Center
Substituted [5,6]cyclic-4(3H)-pyrimidinones as anticancer agentsBDB
Zenji Research Laboratories
Pyridine derivatives and their use in the treatment of cancer and hemoglobinopathiesBDB
Ctxt
PD-1/PD-L1 inhibitorsBDB
Gilead Sciences
Imidazolepyridine compounds and uses thereofBDB
Novartis
Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitorsBDB
Mission Therapeutics
Multi-tyrosine kinase inhibitors derivatives and methods of useBDB
Ontogenesis
Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptorBDB
Bayer Pharma Aktiengesellschaft
HDAC inhibitorsBDB
Biomarin Pharmaceutical
Tricyclic PI3K inhibitor compounds and methods of useBDB
Genentech
Triaza-spirodecanones as DDR1 inhibitorsBDB
Hoffmann-La Roche
Substituted oxopyridine derivativesBDB
Bayer Pharma Aktiengesellschaft
Amino-triazolopyridine compounds and their use in treating cancerBDB
Astrazeneca
Substituted 4-phenylpiperidines, their preparation and useBDB
Columbia University
Compounds and compositions as toll-like receptor 7 agonistsBDB
Novartis
Indolin-2-one derivativesBDB
Hoffmann-La Roche
Cinnoline derivatives useful as CB-1 receptor inverse agonistsBDB
Janssen Pharmaceutica
Pyrrolidine orexin receptor antagonistsBDB
Merck Sharp & Dohme
Pyrazole compounds as CB2 agonistsBDB
Hoffmann-La Roche
Use of T1R3 venus flytrap region polypeptide to screen for taste modulatorsBDB
Senomyx
C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their useBDB
Merck Sharp & Dohme
5-azaindazole compounds and methods of useBDB
F. Hoffmann-La Roche
Tetrahydro-pyrimidoazepines as modulators of TRPV1BDB
Janssen Pharmaceutica
Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.BDB
Yanbian University College of Pharmacy
Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonistsBDB
Euroscreen
Substituted benzimidazolesBDB
Bayer Intellectual Property
Design, synthesis, and urease inhibition studies of some 1,3,4-oxadiazoles and 1,2,4-triazoles derived from mandelic acid.BDB
Quaid-I-Azam University
Structural basis for the recognition of peptide RJPXD33 by acyltransferases in lipid A biosynthesis.BDB
University of Michigan
Compounds as tyrosine kinase modulatorsBDB
Allergan
Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore.BDB
Beni-Suef University
Inhibition of Pax2 Transcription Activation with a Small Molecule that Targets the DNA Binding Domain.BDB
University of Michigan
Heat Capacity Changes for Transition-State Analogue Binding and Catalysis with Human 5'-Methylthioadenosine Phosphorylase.BDB
Albert Einstein College of Medicine
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitorsBDB
University of Utah Research Foundation
Role of the two structural domains from the periplasmic Escherichia coli histidine-binding protein HisJ.BDB
University of Calgary
Inhibitors of Furin and other pro-protein convertasesBDB
Sanford-Burnham Medical Research Institute
3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 deltaBDB
Sanofi
Chromane compoundsBDB
Comentis
Heteroaryl compounds and uses thereofBDB
Celgene Avilomics Research
Phosphoinositide 3-kinase inhibitorsBDB
Respivert
Design, synthesis, and biological characterization of tamibarotene analogs as anticancer agents.BDB
Shandong University
Novel N-allyl/propargyl tetrahydroquinolines: Synthesis via Three-component Cationic Imino Diels-Alder Reaction, Binding Prediction, and Evaluation as Cholinesterase Inhibitors.BDB
Universidad De Talcaa
Tyrosine kinase inhibitorsBDB
Principia Biopharma
Dihydroxy aromatic heterocyclic compoundBDB
Takeda Pharmaceutical
Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors.BDB
Shaoyang University
Triazole compounds that modulate Hsp90 activityBDB
Synta Pharmaceuticals
Haematopoietic-prostaglandin D2 synthase inhibitorsBDB
The University of Queensland
TSH receptor antagonizing tetrahydroquinoline compoundsBDB
Merck Sharp & Dohme
Mediators of hedgehog signaling pathways, compositions and uses related theretoBDB
Curis
Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities.BDB
Pfizer
Factor IXa inhibitorsBDB
Merck Sharp & Dohme
Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitorsBDB
Nerviano Medical Sciences
Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skinBDB
The Procter & Gamble
Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of P2Y1 receptorBDB
Bristol-Myers Squibb
Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disordersBDB
Boehringer Ingelheim International
Heteroaryl sodium channel inhibitorsBDB
Amgen
Tricyclic pyrazol amine derivativesBDB
Merck Serono
Solid-Supported Synthesis and 5-HT7 /5-HT1A Receptor Affinity of Arylpiperazinylbutyl Derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one.BDB
Jagiellonian University Medical College
Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereofBDB
Kissei Pharmaceutical
Agents for reversing epigenetic silencing of genesBDB
The Johns Hopkins University
Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereofBDB
The Leland Stanford Junior University
N1/N2-lactam acetyl-CoA carboxylase inhibitorsBDB
Pfizer
Morpholinyl derivatives useful as MOGAT-2 inhibitorsBDB
Eli Lilly
Selective androgen receptor modulatorsBDB
Radius Health
Heterocyclic derivativesBDB
Novartis
Selective glycosidase inhibitors and uses thereofBDB
Simon Fraser University
Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereofBDB
Boehringer Ingelheim International
Bicyclic compounds and their uses as dual c-SRC/JAK inhibitorsBDB
Debiopharm
Substituted imidazopyridines as HDM2 inhibitorsBDB
Merck Sharp & Dohme
Inhibitors of syk and JAK protein kinasesBDB
Portola Pharmaceuticals
Heteroaromatic compounds as BTK inhibitorsBDB
Boehringer Ingelheim International
Compounds for the inhibition of integrins and use thereofBDB
Shire Orphan Therapies
Depsipeptides and their therapeutic useBDB
Karus Therapeutics
Heterocyclic pyrazole compounds, method for preparing the same and use thereofBDB
Development Center For Biotechnology
Quinoline carboxamide derivatives as protein tyrosine kinase inhibitorsBDB
Novartis
TRPV1 antagonistsBDB
Abbvie
Pyrazolothiazole compoundBDB
Eisai R&D Management
Pyrrolidine derivativesBDB
Hoffmann-La Roche
Selective indole-based ECE inhibitors: synthesis and pharmacological evaluation.BDB
Bayer Healthcare